Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone.
Moncef Belhassen-GarcíaAntonio Sánchez-PuentePedro-Ignacio Dorado-DíazAmparo López-BernúsJesús Sampedro-GómezRaúl Azibeiro-MelchorEdgard Marcano-MillánBeatriz RodriguezMaría-Elisa Sánchez-BarradoIgnacio Hernández-GarcíaIgnacio MadrugaGuillermo Hernández-PérezCristina CarbonellJudit García-AparicioLaura BurgosEugenia López-SánchezCarlos ReinaAna-María RamónLaura Cestero-RamírezFátima BoumhirDaniel Encinas-SánchezMaría Sánchez-LedesmaJacinto HerráezPatricia AraozMaría-José Sánchez-CrespoSandra Rodríguez-RodríguezAna-Elisa Rodríguez-GudeMiguel-Vicente Sánchez-HernándezRafael BorrásVíctor Sagredo-MenesesPedro-Luis SánchezMiguel MarcosJosé-Ángel Martín-OterinoPublished in: Journal of clinical medicine (2021)
MPD and TCZ improved outcomes (death and invasive mechanical ventilation) among hospitalized COVID-19 patients, but confounding variables such as the date of admission during the COVID-19 pandemic should be considered in observational studies.
Keyphrases
- mechanical ventilation
- high dose
- rheumatoid arthritis
- acute respiratory distress syndrome
- juvenile idiopathic arthritis
- emergency department
- intensive care unit
- rheumatoid arthritis patients
- sars cov
- respiratory failure
- low dose
- stem cell transplantation
- disease activity
- extracorporeal membrane oxygenation
- systemic lupus erythematosus
- adipose tissue
- cell therapy
- weight loss
- glycemic control
- replacement therapy